MMP9 and cancer: GMI treatment inhibits tumour necrosis factor alpha (TNFα)‐mediated matrix metallopeptidase 9 (MMP‐9) expression and migration ability of various cancer cells, subsequently impeding tumourigenicity and inducing cell apoptosis in non‐small lung cancer cell lines16[S5,S6].